Cushman & Wakefield Ltd Dossier
Financial Snapshot
Revenue, profitability, returns, debt, and capital allocation
Revenue $10.8B+14.5% YoYTTM through 30 Jun 2026
Net Income $103M-21.6% YoYTTM through 30 Jun 2026
Free Cash Flow $249.1MTTM through 30 Jun 2026
Margins
| Current | |
|---|---|
| Operating Margin | 4.4% |
| Net Margin | 1.0% |
Returns
5.1%ROE
1.1%ROA
2.5%ROIC
Balance Sheet Health
Debt / Equity1.34x
Current Ratio1.10x
Net Debt$2B
Cash & Equivalents$500.5M
Quality Metrics
Altman Z-Score1.84
Piotroski F-Score5 / 9
FCF Margin2.3%
Rule of 405.5
Earnings-Beat Rate100.0%
Multi-Year Trend
RevenueFY2025: $10.3B
Diluted EPS$0.30TTMFY2025: $0.38
Dividend
No dividend
Capital Allocation
Capex Intensity0.5%
Segment Performance
| Segment | Revenue | YoY | Outlook |
|---|---|---|---|
| Americas | $7.5B | ||
| EMEA | $1B | ||
| APAC | $1.8B |
Filing Detail Members
This section is available to registered members. Create a free account or sign in to unlock the full breakdown.